2016
DOI: 10.1097/iae.0000000000001258
|View full text |Cite
|
Sign up to set email alerts
|

Geographic Atrophy

Abstract: Purpose There is a lack of agreement regarding the types of lesions and clinical conditions that should be included in the term “geographic atrophy”. Varied and conflicting views prevail throughout the literature and are currently used by retinal experts and other health care professionals. Methods We reviewed the nominal definition of the term “geographic atrophy” and conducted a search of the ophthalmological literature focusing on preceding terminologies as well as the first citations of the term “geograp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
25
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
4

Relationship

2
7

Authors

Journals

citations
Cited by 64 publications
(25 citation statements)
references
References 57 publications
(62 reference statements)
0
25
0
Order By: Relevance
“…G eographic atrophy (GA) is the non-neovascular late-stage manifestation of AMD. 1,2 Currently, no approved therapy is available for GA while multiple interventional clinical trials are ongoing. 3 Atrophy of the outer retina and RPE are characteristic for GA and also may develop in the presence of the neovascular manifestations (choroidal neovascularization) leading to a significant long-term vision loss despite treatment with anti-VEGF agents.…”
mentioning
confidence: 99%
“…G eographic atrophy (GA) is the non-neovascular late-stage manifestation of AMD. 1,2 Currently, no approved therapy is available for GA while multiple interventional clinical trials are ongoing. 3 Atrophy of the outer retina and RPE are characteristic for GA and also may develop in the presence of the neovascular manifestations (choroidal neovascularization) leading to a significant long-term vision loss despite treatment with anti-VEGF agents.…”
mentioning
confidence: 99%
“…[5][6][7][8][9][10] The term GA in the context of AMD (or "senile macular choroidal degeneration") was originally introduced by Gass in 1970 to describe the funduscopic appearance of circumscribed areas of outer retinal atrophy. 5,11,12 Histologically, GA is characterized by loss of retinal pigment epithelium (RPE) as well as a degeneration of the outer layers of the neurosensory retina and the choriocapillaris. 13,14 Over time, foci of GA tend to slowly enlarge and coalesce with an eventual involvement of the fovea.…”
Section: Introductionmentioning
confidence: 99%
“…13,14 Over time, foci of GA tend to slowly enlarge and coalesce with an eventual involvement of the fovea. 5,11 Among other pathogenetic mechanisms, chronic inflammatory processes, excessive lipofuscin accumulation, complement system dysregulation, and vascular factors have been implicated in the development of AMD. 9,14,15 On fundus autofluorescence (FAF) imaging, areas of GA are clearly defined due to RPE degeneration and the absence of therein contained fluorophores allowing for semi-automated detection and area quantification of atrophic lesions.…”
Section: Introductionmentioning
confidence: 99%
“… 5 Thus, automatic detection and characterization of retinal regions affected by GA is a fundamental and important step for clinical diagnosis, which could aid ophthalmologists in objectively measuring the regions of GA and monitor the evolution of AMD to further make treatment decisions. 6 , 7 GA characterization generally requires accurate segmentation. Manual segmentation is time consuming and subject to interrater variability, which may not produce reliable results especially for large data sets.…”
Section: Introductionmentioning
confidence: 99%